MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation Total Inventories 2011-2026 | NVTA
Annual Total Inventories Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.4 M | 33.5 M | 32 M | 6.6 M | 8.3 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 33.5 M | 6.6 M | 22.2 M |
Quarterly Total Inventories Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.6 M | 20.8 M | 19.1 M | 30.4 M | 29.9 M | 49.1 M | 43.5 M | 33.5 M | 30.6 M | 30 M | 30.7 M | 32 M | 32 M | 32 M | 32 M | 6.65 M | 6.6 M | 6.6 M | 6.6 M | 8.3 M | 8.3 M | 8.3 M | 8.3 M | 5.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 49.1 M | 5.4 M | 22.2 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
123 M | $ 23.41 | 0.47 % | $ 252 M |  China |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 39.7 | 0.92 % | $ 1.1 B | USA |
 |
Co-Diagnostics
CODX
|
1.66 M | $ 6.0 | -3.07 % | $ 176 M | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
560 M | $ 70.68 | 4.87 % | $ 27.3 B | USA |
 |
BioNano Genomics
BNGO
|
13.3 M | $ 1.58 | - | $ 2.01 M | USA |
 |
Guardant Health
GH
|
71.1 M | $ 107.76 | -2.19 % | $ 13.2 B | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | China |
 |
Illumina
ILMN
|
547 M | $ 145.25 | 2.96 % | $ 23.1 B | USA |
 |
CareDx, Inc
CDNA
|
19.5 M | $ 20.41 | 19.15 % | $ 1.1 B | USA |
 |
Danaher Corporation
DHR
|
2.33 B | $ 238.83 | 0.2 % | $ 175 B | USA |
 |
DarioHealth Corp.
DRIO
|
5.06 M | $ 11.97 | -1.56 % | $ 340 M |  Israel |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
68 M | $ 67.28 | -0.41 % | $ 4.66 B | USA |
 |
Exact Sciences Corporation
EXAS
|
162 M | $ 102.23 | 0.11 % | $ 18.9 B | USA |
 |
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | Israel |
 |
Myriad Genetics
MYGN
|
27.5 M | $ 6.56 | -0.3 % | $ 594 M | USA |
 |
Charles River Laboratories International
CRL
|
279 M | $ 219.73 | -0.62 % | $ 11.3 B | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
342 M | $ 1 486.95 | 0.1 % | $ 31.6 B |  Schweiz |
 |
Natera
NTRA
|
35.4 M | $ 233.65 | -0.28 % | $ 23 B | USA |
 |
ENDRA Life Sciences
NDRA
|
2.62 M | $ 4.51 | -3.01 % | $ 2.42 M | USA |
 |
Neogen Corporation
NEOG
|
191 M | $ 9.33 | -3.01 % | $ 2.02 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
188 M | $ 175.05 | 0.34 % | $ 19.4 B | USA |
 |
Organovo Holdings
ONVO
|
297 K | - | -2.3 % | $ 19.4 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
493 M | $ 249.91 | -0.75 % | $ 21 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 180.43 | -0.52 % | $ 14.9 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
382 M | $ 722.17 | 1.24 % | $ 59.6 B | USA |